Patents by Inventor Harlan W. Waksal

Harlan W. Waksal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
    Publication number: 20090297509
    Abstract: A method to inhibit the growth of tumors in human patients, comprising treating the human patients with an effective amount of a combination of radiation and a non-radiolabeled protein receptor tyrosine kinase inhibitor, the overexpression of which can lead to tumorigenesis.
    Type: Application
    Filed: January 26, 2009
    Publication date: December 3, 2009
    Applicant: ImClone Systems Incorporated
    Inventors: Harlan W. Waksal, Mansoor N. Saleh, Francisco Robert, Donald Jay Buchsbaum
  • Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
    Publication number: 20040057950
    Abstract: A method to inhibit the growth of tumors in human patients, comprising treating the human patients with an effective amount of a combination of radiation and a non-radiolabeled protein receptor tyrosine kinase inhibitor, the overexpression of which can lead to tumorigenesis.
    Type: Application
    Filed: September 11, 2003
    Publication date: March 25, 2004
    Inventors: Harlan W. Waksal, Mansoor N. Saleh, Francisco Robert, Donald Jay Buchsbaum
  • Treatment of refractory human tumors with epidermal growth factor receptor antagonists
    Publication number: 20030157104
    Abstract: A method of inhibiting the growth of refractory tumors that are stimulated by a ligand of epidermal growth factor in human patients, comprising treating the human patients with an effective amount of an epidermal growth factor receptor antagonist.
    Type: Application
    Filed: November 30, 2001
    Publication date: August 21, 2003
    Inventor: Harlan W. Waksal
  • Treatment of refractory human tumors with epidermal growth factor receptor antagonists
    Publication number: 20020012663
    Abstract: A method of inhibiting the growth of refractory tumors that are stimulated by a ligand of epidermal growth factor in human patients, comprising treating the human patients with an effective amount of an epidermal growth factor receptor antagonist.
    Type: Application
    Filed: April 24, 2001
    Publication date: January 31, 2002
    Inventor: Harlan W. Waksal
  • Stabilized hepatitis B e antigen suitable for immunoassays
    Patent number: 5501948
    Abstract: Methods and materials for producing hepatitis virus HBe antigenic proteins useful in immunoassays without the necessity of maintaining these proteins in denaturing environments are disclosed. Assay methods and materials utilizing these HBe proteins are also provided.
    Type: Grant
    Filed: June 6, 1994
    Date of Patent: March 26, 1996
    Assignee: ImClone Systems Incorporated
    Inventors: Daniel J. Hicklin, Charles T. Tackney, Harlan W. Waksal